Embryos were preserved by control-rate freezing. Briefly, after 10 min equilibration in 5% glycerol, followed by 10 min in 9% glycerol + 0.2 M sucrose, embryos were individually loaded into 0.25 ml cryostraws and cooled to -150°C in a programmed control-rate freezer (Planer Products Ltd, England) before being plunged into liquid nitrogen (LN 2 ). Embryos were subsequently stored in LN 2 for up to 6 years.
Human Fibroblast Procurement and Culture
Fibroblasts were derived from the foreskin of an approved 8 day old donor under cGMP by Ortec International (USA). Following cell line characterization and biosafety testing (Table S6) under the clinical lines project. The fibroblasts were tested and qualified for hESC derivation and culture. MCBs and WCBs were manufactured under cGMP conditions using pathogen-free fibroblast culture medium (fMedium) comprising DMEM supplemented with 10% FBS and 01% L-glutamine (Table S4 ). Cultures were expanded by passaging with sterile Trypsin/EDTA and cryopreserved by programmed control-rate freezing in fMedium with 10% DMSO as previously described (Table S4 ; Crook et al., 2007) . Fibroblasts prepared for WCBs were mitotically inactivated by γ-irradiation (dose: 25 Grays) immediately prior to freezing. Frozen cell aliquots were plunged into LN 2 until required for hESC derivation and culture. BioReliance (UK) and Charles River Laboratories (Philadelphia, USA) tested all banks negative for microbial contamination, including mycoplasma.
For hESC derivation and expansion, fibroblasts were plated to gelatin-free culture vessels at 6.8 x 10 4 and 3.8 x 10 4 cells/cm 2 respectively by thawing tubes of frozen cells in 37°C sterile water, dilution of cells with 10 ml of fMedium, centrifugation at 300 g for 10 min and removal of supernatant. After resuspension in fMedium and cell viability counting by trypan blue exclusion method, viable cells were immediately plated. fMedium was changed 1 day after plating, and plated feeders were used within 1 week.
hESC Derivation
All donated embryos were transferred to the cGMP facility in LN 2 dry shippers under controlled and monitored conditions and stored in a designated LN 2 tank until required. The embryos were thawed by warming straws at room temperature (RT) for 30 sec and transfer to a 30ºC sterile water bath for 30 -40 sec. Straws were swabbed with 70% EtOH, dried and opened. The contents of a straw were expelled into a culture dish and the embryo was immediately transferred to the first thaw solution. Embryos were then incubated at RT for 10 min successively in 0.5, 0.2 and 0.1 M sucrose-solutions prepared in cryopreservation buffer of a SIVF Thawing Kit (Table S4) , followed by further incubation at RT for 10 min and 37 0 C for 10 min in cryopreservation buffer alone.
Embryos were subsequently transferred into SIVF Blastocyst Medium (Table S4) and cultured for 4 -24 hrs, again in a reduced oxygen atmosphere comprising 6% CO 2 , 5% O 2 and 89% N 2 at 37°C in a K-MINC-1000 incubator. If not fully hatched, the zona pellucida of an embryo was removed by manual bisection using a sterile Ultra-Sharp Splitting Blade (AB Technologies, USA). Depending on embryo quality, it was either bisected to separate ICM and polar trophectoderm from mural trophectoderm, re-plating only the ICM-containing part, or re-plated as a whole embryo. Culture plates comprised fibroblast coated (high concentration: 6.8 x 10 4 cells/cm 2 ) organ culture dishes with USP-grade hESC medium containing custom made KnockOut™ DMEM (KO-DMEM) with high glucose and 20% KnockOut™ SR (KO-SR), 2 mM L-glutamine, 0.1 mM non-essential amino acids and 50 ng/ml recombinant human bFGF (Table S4) .
Following embryo/ICM plating, medium was changed daily.
ICM-outgrowths were first passaged 4 -7 days after plating, and every 4 - (Table S4 ). Total cell number of each batch was determined following trypsinisation of a cell aliquot and Trypan blue exclusion based counting. Cells were control-rate frozen (Crook et al., 2007) in 200 µl of cryomedia in a 0.5 ml CBS ™ High Security Straw (Cryo Bio System, France), hermetically sealed using a thermal sealing unit (Cryo Bio System). Sealed straws of a prospective MCB were maintained at 4 o C until all straws were loaded, prior to freezing. Loaded straws were frozen to -180 o C in a programmed control-rate freezer before being plunged into LN 2 . All MCBs were transported in LN 2 under controlled and monitored conditions to a cGMP-certified storage facility (Cryosite, Australia).
hESC Culture for Line/Bank Characterization
For all hESC lines, cell thawing and culture was performed as described previously (Crook et al., 2007) . In addition, cell culture employed the same reagents used for cGMP cell culture described above. Briefly, thawing of straws for hESC re-culture was performed by rapid transfer from LN 2 storage to sterile 37 o C water. Once thawed, straws were immediately swabbed with 70% EtOH, and dried with sterile lint-free tissue. The ends of each straw were cut and the hESCs expelled by pipette to 37 o C hESC medium and centrifuged at 300 g for 3 min. Pelleted cells were resuspended in fresh 37 o C hESC medium and plated for culture. Following post-thaw recovery, cultures were passaged every 6 -8 days with collagenase, and expanded for subsequent assayology or pathogen testing.
Chromosome and Genotype Analyses
Karyotyping was performed by Sydney Genetics (Australia). For each hESC line, a minimum of 15 metaphase spreads were examined by Giemsa-banding with a chromosome resolution ranging from 200 -400 bands per haploid set.
For DNA fingerprinting studies, samples of 1 -2 x 10 3 hESCs were processed using the Chelex extraction method (Walsh et al., 1991) . Cells were centrifuged at 14,000 g for 5 min and the supernatant removed. Depending on the size of the cell pellet, 100 -200 ml of 5% Chelex (in water) solution was added together with 20 mg/ml Proteinase-K and incubated for 15 -30 min at 56°C. After vortexing for 5 -10 sec the sample was spun briefly, incubated in boiling water for 8 min and vortexed again for 5 -10 sec. After spinning for 2 -3 min the sample was subjected to PCR amplification. An Identifiler kit (Applied Biosystems), which co-amplifies 15 STR loci (CSF1P0, D2S1338, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, D19S433, D21S11, FGA, TH01, TPOX, vWA) in one PCR reaction and the gender marker Amelogenin was used according to the manufacturer's instructions. The samples were analysed using capillary electrophoresis (3100-AVANT Genetic Analyser) and the resulting electropherograms analysed for the allele profile at each locus.
For ESI-013 and ESI-027 fluorescent in-situ hybridization (FISH) studies were performed essentially in accordance with Langer et al. (1981) and Lichter et al. (1988) . A probe specific for the centromere of chromosome 16 (CEP16, Vysis, USA) was hybridized to chromosome preparations according to the manufacturers instructions.
Sterility and Pathogen Testing
Sterility testing was performed under cGMP conditions by "direct inoculation ITS and 0.1mM β-mercaptoethanol), seeded to low attachment tissue culture plates (Corning Costar), and left overnight. SF was then replaced by END2 cellconditioned medium generated by exposure of SF to END2 cells for 4 days (Graichen et al., 2007; Dai et al., 2007) . Medium changes were performed every 3 days. Beating EBs were observed on days 9 -21 of culture and harvested for analysis.
Pancreatic progenitor cells were derived as previously described (D'Alessandro et al., 2007; Phillips et al., 2007) . Briefly, EBs were formed by resuspending freshly collagenased hESCs in ice-cold basal RPMI 1640 medium containing 20% KO-SR, 1x penicillin/streptomycin supplemented with growth factor-reduced Matrigel™ (1:6 dilution; Becton-Dickinson), 50 ng/ml Activin A (R&D) and 50 ng/ml Bmp4 (R&D). The preparation was transferred to ultra low attachment plates (2 ml per well; Corning Costar) and quickly formed a semisolid disc containing EBs of various shapes and sizes at 37° C. Medium changes and growth factor top-ups were as previously described (Phillips et al., 2007) .
Growth Profiling
The growth kinetics of each hESC line was determined by harvesting cells on days 2 and 4 following inoculation and daily thereafter. Cultures were collected in triplicate by collagenase dissociation. Harvested cell aggregates were treated with 0.25% Trypsin-EDTA for 5 min. Triplicate cell samples were counted by trypan blue exclusion method. Viable cell number was plotted against time, and the doubling rate (G) was calculated using the formula G = (Log10 2 / µ) x 24 or (0.301 / µ) x 24, where µ is the specific growth constant (Log10 N 1 -Log10 N 0 / t 1 -t 0 ; where N 0 and N 1 are the number of cells at day 0 (t 0 ) and day 1 (t 1 )) during the exponential growth phase (Choo et al., 2004) . (Table S7) . PCR products were electrophoresed on a 1% agarose gel and visualized by ethidium bromide staining.
Immunophenotyping, RT-PCR and Q-PCR
For Q-PCR total RNA was isolated using Trizol TM (Invitrogen) according to the manufacturer's recommendations followed by cDNA synthesis using standard
protocol. Approximately 50 ng of cDNA template was mixed with 2X Sybr Green PCR Master Mix (BioRad) and diluted to 1X with 100 nM primers (Pdx-1 and β-Actin; Table S7 ) and water. PCR was performed on a BioRad iCycler.
Quantitation was performed according to ∆Ct relative to β-Actin amplification.
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